<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font16 { font-size : 16; } .font17 { font-size : 17; } .font18 { font-size : 18; } .font20 { font-size : 20; } .font21 { font-size : 21; } .font24 { font-size : 24; } .font11 { font-size : 11; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font14 { font-size : 14; } .font31 { font-size : 31; } .font15 { font-size : 15; }</style>
 <body>
  <p>
   <span class="font31">liver </span>
   <span class="font24">hepatitis </span>
   <span class="font21">g/d) </span>
   <span class="font21">hepatoprotective </span>
   <span class="font20">patients </span>
   <span class="font18">TBIL </span>
   <span class="font17">ALT, </span>
   <span class="font17">agents </span>
   <span class="font17">chronic </span>
   <span class="font16">acid </span>
   <span class="font16">treatment </span>
   <span class="font16">fibrosis </span>
   <span class="font15">AST, </span>
   <span class="font15">{border-style </span>
   <span class="font15">clinical </span>
   <span class="font15">px;} </span>
   <span class="font14">#ffffff;} </span>
   <span class="font14">antiviral </span>
   <span class="font14">(WMD </span>
   <span class="font14">UDCA </span>
   <span class="font14">[-., </span>
   <span class="font14">effects </span>
   <span class="font14">ALT </span>
   <span class="font14">agent </span>
   <span class="font14">controlled </span>
   <span class="font14">ursodeoxycholic </span>
   <span class="font13">(). </span>
   <span class="font13">-.; </span>
   <span class="font13">model </span>
   <span class="font13">single </span>
   <span class="font13">vs. </span>
   <span class="font13">randomized </span>
   <span class="font13">trials </span>
   <span class="font13">Hepatoprotective </span>
   <span class="font13">Silibinin </span>
   <span class="font13">silibinin </span>
   <span class="font13">Data </span>
   <span class="font13">Figure </span>
   <span class="font13">combination </span>
   <span class="font13">levels </span>
   <span class="font13">showed </span>
   <span class="font13">using </span>
   <span class="font12">GGT, </span>
   <span class="font12">Hepatitis </span>
   <span class="font12">NAC </span>
   <span class="font12">combined </span>
   <span class="font12">drug </span>
   <span class="font12">drugs </span>
   <span class="font12">efficacy </span>
   <span class="font12">hepatic </span>
   <span class="font12">studies </span>
   <span class="font12">HA, </span>
   <span class="font12">Meta-Analysis </span>
   <span class="font12">cell </span>
   <span class="font12">function </span>
   <span class="font12">protective </span>
   <span class="font12">reported </span>
   <span class="font12">significant </span>
   <span class="font12">used </span>
   <span class="font12">(Figure </span>
   <span class="font12">-.]), </span>
   <span class="font12">Med </span>
   <span class="font12">acetylcysteine </span>
   <span class="font12">confidence </span>
   <span class="font12">current </span>
   <span class="font12">px; </span>
   <span class="font12">treat </span>
   <span class="font12">{font-family </span>
   <span class="font11">ALP </span>
   <span class="font11">ALP, </span>
   <span class="font11">Agents </span>
   <span class="font11">Forest </span>
   <span class="font11">Liver </span>
   <span class="font11">PIIIP </span>
   <span class="font11">Plots </span>
   <span class="font11">compared </span>
   <span class="font11">font-size </span>
   <span class="font11">group </span>
   <span class="font11">infection </span>
   <span class="font11">pooled </span>
   <span class="font11">presented </span>
   <span class="font11">reduce </span>
   <span class="font11">study </span>
   <span class="font11">terms </span>
   <span class="font11">used. </span>
   <span class="font11">(Table </span>
   <span class="font11">Effects </span>
   <span class="font11">LN, </span>
   <span class="font11">Placebo </span>
   <span class="font11">cirrhosis </span>
   <span class="font11">difference </span>
   <span class="font11">disease </span>
   <span class="font11">double; </span>
   <span class="font11">effect </span>
   <span class="font11">heterogeneity </span>
   <span class="font11">mean </span>
   <span class="font11">promote </span>
   <span class="font11">serum </span>
   <span class="font11">severe </span>
   <span class="font11">statistically </span>
   <span class="font11">therapy </span>
   <span class="font11">treated </span>
   <span class="font11">versus </span>
   <span class="font11">AST </span>
   <span class="font11">Basic </span>
   <span class="font11">IV-C </span>
   <span class="font11">Med. </span>
   <span class="font11">Meta-analysis </span>
   <span class="font11">basic </span>
   <span class="font11">bile </span>
   <span class="font11">border-color </span>
   <span class="font11">border-width </span>
   <span class="font11">effective </span>
   <span class="font11">improve </span>
   <span class="font11">indexes </span>
   <span class="font11">injection </span>
   <span class="font11">intervals. </span>
   <span class="font11">qod </span>
   <span class="font11">random-effects </span>
   <span class="font11">silymarin </span>
   <span class="font11">solid; </span>
   <span class="font11">subjects </span>
   <span class="font11">subjects, </span>
   <span class="font11">test </span>
   <span class="font11">viral </span>
   <span class="font11">{font-style </span>
   <span class="font11">{font-weight </span>
   <span class="font11">&amp;gt; </span>
   <span class="font11">&amp;lt; </span>
   <span class="font11">(No. </span>
   <span class="font11">(unclear) </span>
   <span class="font11">-., </span>
   <span class="font11">.]) </span>
   <span class="font11">Funnel </span>
   <span class="font11">Group </span>
   <span class="font11">HBV </span>
   <span class="font11">Lamivudine </span>
   <span class="font11">Levels </span>
   <span class="font11">N-acetylcysteine </span>
   <span class="font11">Patients </span>
   <span class="font11">Results </span>
   <span class="font11">TBIL, </span>
   <span class="font11">agent. </span>
   <span class="font11">better </span>
   <span class="font11">biliary </span>
   <span class="font11">bold </span>
   <span class="font11">control </span>
   <span class="font11">courier; </span>
   <span class="font11">course </span>
   <span class="font11">em; </span>
   <span class="font11">evaluate </span>
   <span class="font11">fibrosis, </span>
   <span class="font11">groups </span>
   <span class="font11">included </span>
   <span class="font11">including </span>
   <span class="font11">indicators </span>
   <span class="font11">meta-analysis </span>
   <span class="font11">mg/d </span>
   <span class="font11">million </span>
   <span class="font11">normalization </span>
   <span class="font11">plot </span>
   <span class="font11">primary </span>
   <span class="font11">pt;} </span>
   <span class="font11">recovery </span>
   <span class="font11">significantly </span>
   <span class="font11">superior </span>
   <span class="font11">total </span>
  </p>
 </body>
</html>
